Wellington Management Group
SANA icon

Wellington Management Group’s Sana Biotechnology SANA Stock Holding History

Wellington Management Group’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-34,376
Closed -$344K – 1960
2024
Q1 		$344K Buy
+34,376
New +$258K ﹤0.01% 1842
2021
Q3 		– Sell
-828,587
Closed -$16.3M – 2251
2021
Q2 		$16.3M Buy
828,587
+293,523
+55% +$6.65M ﹤0.01% 1140
2021
Q1 		$17.9M Buy
+535,064
New +$17.4M ﹤0.01% 1101

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group's SANA Position: Q2 2024 in Review

Wellington Management Group sold out of Sana Biotechnology (SANA) in Q2 2024, closing a stake of 34,376 shares — an estimated $344K sold.

Wellington Management Group first reported a position in SANA in Q1 2021 and held it in 3 quarters. The position peaked at $17.9M in Q1 2021. 148 funds tracked by Wall St. Rank hold SANA as of Q2 2024.

  • Wellington Management Group reported no remaining Sana Biotechnology position as of Q2 2024 after selling out during the quarter.
  • Wellington Management Group sold 34,376 Sana Biotechnology shares in Q2 2024, an estimated $344K.
  • Wellington Management Group first reported a position in Sana Biotechnology in Q1 2021 and held it in 3 quarters.
  • Wellington Management Group's Sana Biotechnology position peaked at $17.9M in Q1 2021.
  • 148 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2024.

Based on Wellington Management Group's 13F filing for Q2 2024, filed 14 Aug 2024.